Literature DB >> 22824108

Cardiovascular biomarkers in exhaled breath.

Frank S Cikach1, Raed A Dweik.   

Abstract

With each breath that we exhale, thousands of molecules are expelled in our breath, giving individuals a "breath-print" that can tell a lot about them and their state of health. Breath analysis is rapidly evolving as the new frontier in medical testing. The end of the 20th century and the beginning of the 21st century have arguably witnessed a revolution in our understanding of the constituents of exhaled breath and the development of the field of breath analysis and testing. Thanks to major breakthroughs in new technologies (infrared, electrochemical, chemiluminescence, and others) and the availability of mass spectrometers, the field of breath analysis has made considerable advances in the 21st century. Several methods are now in clinical use or nearly ready to enter that arena. Breath analysis has the potential to offer relatively inexpensive, rapid, noninvasive methods for detecting and/or monitoring a variety of diseases. Breath analysis also has applications in fields beyond medicine, including environmental monitoring, security, and others. This review will focus on exhaled breath as a potential source of biomarkers for medical applications with specific attention to applications (and potential applications) in cardiovascular disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22824108      PMCID: PMC4205725          DOI: 10.1016/j.pcad.2012.05.005

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  62 in total

1.  Carbon monoxide-induced vasorelaxation and the underlying mechanisms.

Authors:  R Wang; Z Wang; L Wu
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

2.  Pulmonary hypertension and the search for the selective pulmonary vasodilator.

Authors:  Raed A Dweik
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

3.  Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans.

Authors:  L E Gustafsson; A M Leone; M G Persson; N P Wiklund; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

4.  Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds.

Authors:  J D Pleil; A B Lindstrom
Journal:  Clin Chem       Date:  1997-05       Impact factor: 8.327

Review 5.  The lung in the balance: arginine, methylated arginines, and nitric oxide.

Authors:  Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-09-15       Impact factor: 5.464

6.  The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.

Authors:  Philip E Silkoff; Mats Carlson; Trevor Bourke; Rohit Katial; Elisabeth Ogren; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

Review 7.  Exhaled nitric oxide in pulmonary diseases: a comprehensive review.

Authors:  Peter J Barnes; Raed A Dweik; Arthur F Gelb; Peter G Gibson; Steven C George; Hartmut Grasemann; Ian D Pavord; Felix Ratjen; Philip E Silkoff; D Robin Taylor; Noe Zamel
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

8.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

Authors:  Andrew D Smith; Jan O Cowan; Karen P Brassett; G Peter Herbison; D Robin Taylor
Journal:  N Engl J Med       Date:  2005-05-24       Impact factor: 91.245

9.  Exhaled breath analysis: The new interface between medicine and engineering.

Authors:  Alquam Mashir; Raed A Dweik
Journal:  Adv Powder Technol       Date:  2009-09       Impact factor: 4.833

10.  Nitric oxide and pulmonary arterial pressures in pulmonary hypertension.

Authors:  Roberto F Machado; Medha-Vini Londhe Nerkar; Raed A Dweik; Jeffrey Hammel; Allison Janocha; Jacqueline Pyle; Daniel Laskowski; Constance Jennings; Alejandro C Arroliga; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2004-10-01       Impact factor: 7.376

View more
  19 in total

Review 1.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

Review 2.  Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Authors:  Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

3.  Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls.

Authors:  N Alkhouri; K Eng; F Cikach; N Patel; C Yan; A Brindle; E Rome; I Hanouneh; D Grove; R Lopez; S L Hazen; Raed A Dweik
Journal:  Pediatr Obes       Date:  2014-03-27       Impact factor: 4.000

4.  The breath print represents a novel biomarker of malnutrition in pulmonary arterial hypertension: A proof of concept study.

Authors:  Jacob T Mey; Mary C Rath; Kathleen McLaughlin; Marianne Galang; Kathryn Lynch; Jaime DiMattio; Hillary Nason; Shengping Yang; Celia A Melillo; David E Grove; Adriano R Tonelli; Gustavo A Heresi; John P Kirwan; Raed A Dweik
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-11-12       Impact factor: 3.896

5.  Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Authors:  Sarah K Himes; Karl B Scheidweiler; Olof Beck; David A Gorelick; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-17       Impact factor: 8.327

6.  Breath analysis in pulmonary arterial hypertension.

Authors:  Frank S Cikach; Adriano R Tonelli; Jarrod Barnes; Kelly Paschke; Jennie Newman; David Grove; Luma Dababneh; Sihe Wang; Raed A Dweik
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

7.  Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure.

Authors:  Michael A Samara; W H Wilson Tang; Frank Cikach; Zeynep Gul; Lily Tranchito; Kelly M Paschke; Jamie Viterna; Yuping Wu; Daniel Laskowski; Raed A Dweik
Journal:  J Am Coll Cardiol       Date:  2013-04-02       Impact factor: 24.094

Review 8.  Metabolic Biomarkers in Heart Failure.

Authors:  Chonyang L Albert; W H Wilson Tang
Journal:  Heart Fail Clin       Date:  2018-01       Impact factor: 3.179

9.  Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine.

Authors:  Patrick A Gladding; Andrew Cave; Mehran Zareian; Kevin Smith; Jagir Hussan; Peter Hunter; Folarin Erogbogbo; Zoraida Aguilar; David S Martin; Eugene Chan; Margie L Homer; Abhijit V Shevade; Mohammad Kassemi; James D Thomas; Todd T Schlegel
Journal:  J Pers Med       Date:  2013-08-21

10.  Elevated carbon monoxide to carbon dioxide ratio in the exhaled breath of mice treated with a single dose of lipopolysaccharide.

Authors:  Arash Ghalyanchi Langeroudi; Charlotte M Hirsch; Azadeh Shojaee Estabragh; Simone Meinardi; Donald R Blake; Alan G Barbour
Journal:  Open Forum Infect Dis       Date:  2014-09-18       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.